{"id":"https://openalex.org/W4387809681","doi":"https://doi.org/10.1016/j.annonc.2023.10.043","title":"LBA49 mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response","display_name":"LBA49 mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response","publication_year":2023,"publication_date":"2023-10-01","ids":{"openalex":"https://openalex.org/W4387809681","doi":"https://doi.org/10.1016/j.annonc.2023.10.043"},"language":"en","primary_location":{"id":"doi:10.1016/j.annonc.2023.10.043","doi":"https://doi.org/10.1016/j.annonc.2023.10.043","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.10.043","pdf_url":"http://www.annalsofoncology.org/article/S092375342304187X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.annalsofoncology.org/article/S092375342304187X/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047177507","display_name":"Jeffrey S. Weber","orcid":"https://orcid.org/0000-0002-4962-2957","observed_orcids":["https://orcid.org/0000-0002-4962-2957"]},"institutions":[{"id":"https://openalex.org/I4390039310","display_name":"NYU Langone\u2019s Laura and Isaac Perlmutter Cancer Center","ror":"https://ror.org/00sa8g751","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933","https://openalex.org/I4390039310"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.S. Weber","raw_affiliation_strings":["Perlmutter Cancer Center, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perlmutter Cancer Center, Laura and Isaac Perlmutter Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I4390039310"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112390975","display_name":"Adnan Khattak","orcid":"https://orcid.org/0000-0002-4633-3818","observed_orcids":["https://orcid.org/0000-0002-4633-3818","https://orcid.org/0009-0008-2954-119X"]},"institutions":[{"id":"https://openalex.org/I12079687","display_name":"Edith Cowan University","ror":"https://ror.org/05jhnwe22","country_code":"AU","type":"education","lineage":["https://openalex.org/I12079687"]},{"id":"https://openalex.org/I2800639565","display_name":"Hollywood Private Hospital","ror":"https://ror.org/0101aa973","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800639565"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"A. Khattak","raw_affiliation_strings":["Medical Oncology, Hollywood Private Hospital & Edith Cowan University, Perth, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Hollywood Private Hospital & Edith Cowan University, Perth, WA, Australia","institution_ids":["https://openalex.org/I12079687","https://openalex.org/I2800639565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083061830","display_name":"Matteo Salvatore Carlino","orcid":"https://orcid.org/0000-0002-7861-4104","observed_orcids":["https://orcid.org/0000-0002-7861-4104"]},"institutions":[{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"M. Carlino","raw_affiliation_strings":["Medical Oncology Department, Crown Princess Mary Cancer Centre Westmead, Westmead, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Crown Princess Mary Cancer Centre Westmead, Westmead, NSW, Australia","institution_ids":["https://openalex.org/I2803024705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008479799","display_name":"Ryan Joseph Sullivan","orcid":"https://orcid.org/0000-0001-5344-6645","observed_orcids":["https://orcid.org/0000-0001-5344-6645"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.J. Sullivan","raw_affiliation_strings":["Oncology, MGH - Massachusetts General Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, MGH - Massachusetts General Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063337705","display_name":"Jason J. Luke","orcid":"https://orcid.org/0000-0002-1182-4908","observed_orcids":["https://orcid.org/0000-0002-1182-4908"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.J. Luke","raw_affiliation_strings":["Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073719611","display_name":"Tarek M. Meniawy","orcid":"https://orcid.org/0000-0002-1457-6137","observed_orcids":["https://orcid.org/0000-0002-1457-6137"]},"institutions":[{"id":"https://openalex.org/I1292109108","display_name":"St John of God Subiaco Hospital","ror":"https://ror.org/00hvh1x59","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1292109108"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"T. Meniawy","raw_affiliation_strings":["Oncology, Saint John of God Subiaco Hospital, Subiaco, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Saint John of God Subiaco Hospital, Subiaco, WA, Australia","institution_ids":["https://openalex.org/I1292109108"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033482846","display_name":"Matthew Hiram Taylor","orcid":"https://orcid.org/0000-0003-2409-9001","observed_orcids":["https://orcid.org/0000-0003-2409-9001"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Taylor","raw_affiliation_strings":["Medical Oncology, Providence Cancer Institute, Southfield, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Providence Cancer Institute, Southfield, MI, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080536692","display_name":"George Ansstas","orcid":"https://orcid.org/0000-0002-7178-8777","observed_orcids":["https://orcid.org/0000-0002-7178-8777"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Ansstas","raw_affiliation_strings":["Oncology, Washington University School of Medicine in St. Louis - Siteman Cancer Center, St. Louis, MO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Washington University School of Medicine in St. Louis - Siteman Cancer Center, St. Louis, MO, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023549047","display_name":"K. Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801780550","display_name":"California Pacific Medical Center","ror":"https://ror.org/02bjh0167","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114073160","https://openalex.org/I2801780550"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Kim","raw_affiliation_strings":["Oncology, California Pacific Medical Center Research Institute, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, California Pacific Medical Center Research Institute, San Francisco, CA, USA","institution_ids":["https://openalex.org/I2801780550"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002575629","display_name":"Meredith Ann McKean","orcid":"https://orcid.org/0000-0003-0944-7418","observed_orcids":["https://orcid.org/0000-0003-0944-7418"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Mckean","raw_affiliation_strings":["Drug Development Unit, Sarah Cannon Research Institute, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Unit, Sarah Cannon Research Institute, Nashville, TN, USA","institution_ids":["https://openalex.org/I4210100810"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080404941","display_name":"Mark B. Faries","orcid":"https://orcid.org/0000-0003-1752-7282","observed_orcids":["https://orcid.org/0000-0003-1752-7282"]},"institutions":[{"id":"https://openalex.org/I4210104507","display_name":"Angeles Clinic and Research Institute","ror":"https://ror.org/01ct2ab72","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834","https://openalex.org/I4210104507"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Faries","raw_affiliation_strings":["Onocology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Onocology, The Angeles Clinic and Research Institute, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210104507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113516618","display_name":"Tam Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Tran","raw_affiliation_strings":["Oncology, Yale University School of Medicine - Yale Cancer Center, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Yale University School of Medicine - Yale Cancer Center, New Haven, CT, USA","institution_ids":["https://openalex.org/I2802730090","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025809703","display_name":"Charles Lance Cowey","orcid":"https://orcid.org/0000-0001-8597-8486","observed_orcids":["https://orcid.org/0000-0001-8597-8486"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.L. Cowey","raw_affiliation_strings":["Oncology, Texas Oncology - Baylor Sammons Cancer Center, Dallas, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Texas Oncology - Baylor Sammons Cancer Center, Dallas, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033513950","display_name":"Andrew L. Pecora","orcid":"https://orcid.org/0000-0002-8368-0632","observed_orcids":["https://orcid.org/0000-0002-8368-0632"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Pecora","raw_affiliation_strings":["Oncology, John Theurer Cancer Center - Hackensack University Medical Center, Hackensack, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, John Theurer Cancer Center - Hackensack University Medical Center, Hackensack, NJ, USA","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029723783","display_name":"Theresa Michelle Medina","orcid":"https://orcid.org/0000-0003-0579-4121","observed_orcids":["https://orcid.org/0000-0003-0579-4121"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]},{"id":"https://openalex.org/I51713134","display_name":"University of Colorado Anschutz","ror":"https://ror.org/03wmf1y16","country_code":"US","type":"education","lineage":["https://openalex.org/I51713134"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Medina","raw_affiliation_strings":["Medical Oncology - Cutaneous Oncology Department, University of Colorado Cancer Center Anschutz Cancer Pavilion, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology - Cutaneous Oncology Department, University of Colorado Cancer Center Anschutz Cancer Pavilion, Aurora, CO, USA","institution_ids":["https://openalex.org/I4210134151","https://openalex.org/I51713134"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110537497","display_name":"Victoria G. Atkinson","orcid":"https://orcid.org/0000-0002-9806-9019","observed_orcids":["https://orcid.org/0000-0002-9806-9019"]},"institutions":[{"id":"https://openalex.org/I2801814493","display_name":"Princess Alexandra Hospital","ror":"https://ror.org/04mqb0968","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I2801814493","https://openalex.org/I4210089726"]},{"id":"https://openalex.org/I4210089726","display_name":"Metro South Health","ror":"https://ror.org/016gd3115","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I4210089726"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"V.G. Atkinson","raw_affiliation_strings":["Division of Cancer Services, Princess Alexandra Hospital - Metro South Health, Woolloongabba, QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Services, Princess Alexandra Hospital - Metro South Health, Woolloongabba, QLD, Australia","institution_ids":["https://openalex.org/I2801814493","https://openalex.org/I4210089726"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026672076","display_name":"Geoffrey Thomas Gibney","orcid":"https://orcid.org/0000-0002-5401-8498","observed_orcids":["https://orcid.org/0000-0002-5401-8498"]},"institutions":[{"id":"https://openalex.org/I4390039356","display_name":"Georgetown Lombardi Comprehensive Cancer Center","ror":"https://ror.org/035zrb927","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184565670","https://openalex.org/I4390039356"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Gibney","raw_affiliation_strings":["Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington DC, USA","institution_ids":["https://openalex.org/I4390039356"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066489948","display_name":"Elizabeth Iannotti Buchbinder","orcid":"https://orcid.org/0000-0002-7979-8953","observed_orcids":["https://orcid.org/0000-0002-7979-8953","https://orcid.org/0000-0003-4626-1612"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Buchbinder","raw_affiliation_strings":["Medical Oncology Department, Dana Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Dana Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088227922","display_name":"Robert S. Meehan","orcid":"https://orcid.org/0009-0009-4794-1477","observed_orcids":["https://orcid.org/0009-0009-4794-1477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Meehan","raw_affiliation_strings":["Oncology, Moderna, Inc. - Global Headquarters, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Moderna, Inc. - Global Headquarters, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"G.V. Long","raw_affiliation_strings":["Oncology, Melanoma Institute Australia, Wollstonecraft, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Melanoma Institute Australia, Wollstonecraft, NSW, Australia","institution_ids":["https://openalex.org/I4210118383"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":21,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4060,"currency":"USD","value_usd":4060},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":null,"first_page":"S1288","last_page":"S1289"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6963000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6963000297546387,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.2827000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/resected-melanoma","display_name":"resected melanoma","score":0.7860000133514404},{"id":"https://openalex.org/keywords/circulating-tumor-dna","display_name":"circulating tumor DNA","score":0.8460000157356262},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.7799999713897705},{"id":"https://openalex.org/keywords/distant-metastasis-free-survival","display_name":"distant metastasis-free survival","score":0.9940000176429749},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6119999885559082},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7725968360900879},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7158978581428528},{"id":"https://openalex.org/C2781335228","wikidata":"https://www.wikidata.org/wiki/Q19596321","display_name":"Circulating tumor DNA","level":3,"score":0.6342645883560181},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6122607588768005},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5555353164672852},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.46254393458366394},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.45981770753860474},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3394094705581665},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2080618441104889},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.18436649441719055}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.annonc.2023.10.043","doi":"https://doi.org/10.1016/j.annonc.2023.10.043","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.10.043","pdf_url":"http://www.annalsofoncology.org/article/S092375342304187X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.annonc.2023.10.043","doi":"https://doi.org/10.1016/j.annonc.2023.10.043","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.annonc.2023.10.043","pdf_url":"http://www.annalsofoncology.org/article/S092375342304187X/pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320308982","display_name":"American Society of Clinical Oncology","ror":"https://ror.org/04fy6j421"},{"id":"https://openalex.org/F4320311073","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524"},{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"},{"id":"https://openalex.org/F4320312140","display_name":"Exelixis","ror":"https://ror.org/01e3jga91"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320314605","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38"},{"id":"https://openalex.org/F4320315449","display_name":"Tizona Therapeutics","ror":"https://ror.org/0465c4575"},{"id":"https://openalex.org/F4320316539","display_name":"Foghorn Therapeutics","ror":"https://ror.org/05j5rbv93"},{"id":"https://openalex.org/F4320317235","display_name":"BeiGene","ror":"https://ror.org/012v2c923"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320319071","display_name":"Moderna","ror":"https://ror.org/01xm4wg91"},{"id":"https://openalex.org/F4320319266","display_name":"G1 Therapeutics","ror":"https://ror.org/048389405"},{"id":"https://openalex.org/F4320319326","display_name":"Castle Biosciences","ror":"https://ror.org/04mp5e251"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320331537","display_name":"Qbiotics","ror":null},{"id":"https://openalex.org/F4320331709","display_name":"Mereo BioPharma","ror":"https://ror.org/02g73z327"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"},{"id":"https://openalex.org/F4320332200","display_name":"EMD Serono","ror":"https://ror.org/027zrs220"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387809681.pdf","grobid_xml":"https://content.openalex.org/works/W4387809681.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399451701","https://openalex.org/W4379662277","https://openalex.org/W4402561140","https://openalex.org/W4379662180","https://openalex.org/W4391067309","https://openalex.org/W4409624268","https://openalex.org/W4381283833","https://openalex.org/W4381283513","https://openalex.org/W7128727502","https://openalex.org/W4242587051"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2023-10-21T00:00:00"}